▶ 調査レポート

世界の診断核医学市場:専門的調査

• 英文タイトル:Global Diagnostic Nuclear Medicines Market Professional Survey Report 2019

QYResearchが調査・発行した産業分析レポートです。世界の診断核医学市場:専門的調査 / Global Diagnostic Nuclear Medicines Market Professional Survey Report 2019 / QYR9ST09763資料のイメージです。• レポートコード:QYR9ST09763
• 出版社/出版日:QYResearch / 2019年9月5日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、110ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥518,000 (USD3,500)▷ お問い合わせ
  Enterprise License¥1,036,000 (USD7,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※本調査レポートは、診断核医学の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、Tc-99m、F-18、その他に、用途別には、腫瘍学、循環器、その他にセグメント区分し、診断核医学の世界市場を分析しました。


・エグゼクティブ・サマリー
・診断核医学の世界市場概要
・診断核医学の製造コスト構成分析
・診断核医学の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・診断核医学の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・診断核医学のセグメント分析(種類別)
(Tc-99m、F-18、その他)
・診断核医学のセグメント分析(用途別)
(腫瘍学、循環器、その他)
・診断核医学の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Bracco Imaging、Bayer、Curium Pharmaceuticals、Nordion、Triad Isotopes、Lantheus、GE Healthcare、China Isotope & Radiation、Jubilant Pharma、Eli Lilly、Novartis、SIEMENS、Dongcheng、Navidea)
・診断核医学の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...

Diagnostic radiopharmaceuticals. Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis
The global Diagnostic Nuclear Medicines market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Diagnostic Nuclear Medicines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Diagnostic Nuclear Medicines market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Diagnostic Nuclear Medicines in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Diagnostic Nuclear Medicines manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Bracco Imaging
Bayer
Curium Pharmaceuticals
Nordion
Triad Isotopes
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
SIEMENS
Dongcheng
Navidea

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Tc-99m
F-18
Other

Segment by Application
Oncology
Cardiology
Other

レポート目次

Table of Contents

Executive Summary
1 Industry Overview of Diagnostic Nuclear Medicines
1.1 Definition of Diagnostic Nuclear Medicines
1.2 Diagnostic Nuclear Medicines Segment by Type
1.2.1 Global Diagnostic Nuclear Medicines Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Tc-99m
1.2.3 F-18
1.2.4 Other
1.3 Diagnostic Nuclear Medicines Segment by Applications
1.3.1 Global Diagnostic Nuclear Medicines Consumption Comparison by Applications (2014-2025)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Diagnostic Nuclear Medicines Overall Market
1.4.1 Global Diagnostic Nuclear Medicines Revenue (2014-2025)
1.4.2 Global Diagnostic Nuclear Medicines Production (2014-2025)
1.4.3 North America Diagnostic Nuclear Medicines Status and Prospect (2014-2025)
1.4.4 Europe Diagnostic Nuclear Medicines Status and Prospect (2014-2025)
1.4.5 China Diagnostic Nuclear Medicines Status and Prospect (2014-2025)
1.4.6 Japan Diagnostic Nuclear Medicines Status and Prospect (2014-2025)
1.4.7 Southeast Asia Diagnostic Nuclear Medicines Status and Prospect (2014-2025)
1.4.8 India Diagnostic Nuclear Medicines Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Diagnostic Nuclear Medicines
2.3 Manufacturing Process Analysis of Diagnostic Nuclear Medicines
2.4 Industry Chain Structure of Diagnostic Nuclear Medicines

3 Development and Manufacturing Plants Analysis of Diagnostic Nuclear Medicines
3.1 Capacity and Commercial Production Date
3.2 Global Diagnostic Nuclear Medicines Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Diagnostic Nuclear Medicines
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Diagnostic Nuclear Medicines Production and Capacity Analysis
4.2 Diagnostic Nuclear Medicines Revenue Analysis
4.3 Diagnostic Nuclear Medicines Price Analysis
4.4 Market Concentration Degree

5 Diagnostic Nuclear Medicines Regional Market Analysis
5.1 Diagnostic Nuclear Medicines Production by Regions
5.1.1 Global Diagnostic Nuclear Medicines Production by Regions
5.1.2 Global Diagnostic Nuclear Medicines Revenue by Regions
5.2 Diagnostic Nuclear Medicines Consumption by Regions
5.3 North America Diagnostic Nuclear Medicines Market Analysis
5.3.1 North America Diagnostic Nuclear Medicines Production
5.3.2 North America Diagnostic Nuclear Medicines Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Diagnostic Nuclear Medicines Import and Export
5.4 Europe Diagnostic Nuclear Medicines Market Analysis
5.4.1 Europe Diagnostic Nuclear Medicines Production
5.4.2 Europe Diagnostic Nuclear Medicines Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Diagnostic Nuclear Medicines Import and Export
5.5 China Diagnostic Nuclear Medicines Market Analysis
5.5.1 China Diagnostic Nuclear Medicines Production
5.5.2 China Diagnostic Nuclear Medicines Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Diagnostic Nuclear Medicines Import and Export
5.6 Japan Diagnostic Nuclear Medicines Market Analysis
5.6.1 Japan Diagnostic Nuclear Medicines Production
5.6.2 Japan Diagnostic Nuclear Medicines Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Diagnostic Nuclear Medicines Import and Export
5.7 Southeast Asia Diagnostic Nuclear Medicines Market Analysis
5.7.1 Southeast Asia Diagnostic Nuclear Medicines Production
5.7.2 Southeast Asia Diagnostic Nuclear Medicines Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Diagnostic Nuclear Medicines Import and Export
5.8 India Diagnostic Nuclear Medicines Market Analysis
5.8.1 India Diagnostic Nuclear Medicines Production
5.8.2 India Diagnostic Nuclear Medicines Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Diagnostic Nuclear Medicines Import and Export

6 Diagnostic Nuclear Medicines Segment Market Analysis (by Type)
6.1 Global Diagnostic Nuclear Medicines Production by Type
6.2 Global Diagnostic Nuclear Medicines Revenue by Type
6.3 Diagnostic Nuclear Medicines Price by Type

7 Diagnostic Nuclear Medicines Segment Market Analysis (by Application)
7.1 Global Diagnostic Nuclear Medicines Consumption by Application
7.2 Global Diagnostic Nuclear Medicines Consumption Market Share by Application (2014-2019)

8 Diagnostic Nuclear Medicines Major Manufacturers Analysis
8.1 Bracco Imaging
8.1.1 Bracco Imaging Diagnostic Nuclear Medicines Production Sites and Area Served
8.1.2 Bracco Imaging Product Introduction, Application and Specification
8.1.3 Bracco Imaging Diagnostic Nuclear Medicines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bayer
8.2.1 Bayer Diagnostic Nuclear Medicines Production Sites and Area Served
8.2.2 Bayer Product Introduction, Application and Specification
8.2.3 Bayer Diagnostic Nuclear Medicines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Curium Pharmaceuticals
8.3.1 Curium Pharmaceuticals Diagnostic Nuclear Medicines Production Sites and Area Served
8.3.2 Curium Pharmaceuticals Product Introduction, Application and Specification
8.3.3 Curium Pharmaceuticals Diagnostic Nuclear Medicines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Nordion
8.4.1 Nordion Diagnostic Nuclear Medicines Production Sites and Area Served
8.4.2 Nordion Product Introduction, Application and Specification
8.4.3 Nordion Diagnostic Nuclear Medicines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Triad Isotopes
8.5.1 Triad Isotopes Diagnostic Nuclear Medicines Production Sites and Area Served
8.5.2 Triad Isotopes Product Introduction, Application and Specification
8.5.3 Triad Isotopes Diagnostic Nuclear Medicines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Lantheus
8.6.1 Lantheus Diagnostic Nuclear Medicines Production Sites and Area Served
8.6.2 Lantheus Product Introduction, Application and Specification
8.6.3 Lantheus Diagnostic Nuclear Medicines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 GE Healthcare
8.7.1 GE Healthcare Diagnostic Nuclear Medicines Production Sites and Area Served
8.7.2 GE Healthcare Product Introduction, Application and Specification
8.7.3 GE Healthcare Diagnostic Nuclear Medicines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 China Isotope & Radiation
8.8.1 China Isotope & Radiation Diagnostic Nuclear Medicines Production Sites and Area Served
8.8.2 China Isotope & Radiation Product Introduction, Application and Specification
8.8.3 China Isotope & Radiation Diagnostic Nuclear Medicines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Jubilant Pharma
8.9.1 Jubilant Pharma Diagnostic Nuclear Medicines Production Sites and Area Served
8.9.2 Jubilant Pharma Product Introduction, Application and Specification
8.9.3 Jubilant Pharma Diagnostic Nuclear Medicines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Eli Lilly
8.10.1 Eli Lilly Diagnostic Nuclear Medicines Production Sites and Area Served
8.10.2 Eli Lilly Product Introduction, Application and Specification
8.10.3 Eli Lilly Diagnostic Nuclear Medicines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Novartis
8.12 SIEMENS
8.13 Dongcheng
8.14 Navidea

9 Development Trend of Analysis of Diagnostic Nuclear Medicines Market
9.1 Global Diagnostic Nuclear Medicines Market Trend Analysis
9.1.1 Global Diagnostic Nuclear Medicines Market Size (Volume and Value) Forecast 2019-2025
9.2 Diagnostic Nuclear Medicines Regional Market Trend
9.2.1 North America Diagnostic Nuclear Medicines Forecast 2019-2025
9.2.2 Europe Diagnostic Nuclear Medicines Forecast 2019-2025
9.2.3 China Diagnostic Nuclear Medicines Forecast 2019-2025
9.2.4 Japan Diagnostic Nuclear Medicines Forecast 2019-2025
9.2.5 Southeast Asia Diagnostic Nuclear Medicines Forecast 2019-2025
9.2.6 India Diagnostic Nuclear Medicines Forecast 2019-2025
9.3 Diagnostic Nuclear Medicines Market Trend (Product Type)
9.4 Diagnostic Nuclear Medicines Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Diagnostic Nuclear Medicines Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Diagnostic Nuclear Medicines
Table Global Diagnostic Nuclear Medicines Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global Diagnostic Nuclear Medicines Production Market Share by Types in 2018
Figure Tc-99m Product Picture
Figure F-18 Product Picture
Figure Other Product Picture
Table Global Diagnostic Nuclear Medicines Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global Diagnostic Nuclear Medicines Consumption Market Share by Applications in 2018
Figure Oncology
Figure Cardiology
Figure Other
Figure Global Diagnostic Nuclear Medicines Revenue (Million USD) (2014-2025)
Figure Global Diagnostic Nuclear Medicines Production (K Units) (2014-2025)
Figure North America Diagnostic Nuclear Medicines Market Size (Million USD) (2014-2025)
Figure Europe Diagnostic Nuclear Medicines Market Size (Million USD) (2014-2025)
Figure China Diagnostic Nuclear Medicines Market Size (Million USD) (2014-2025)
Figure Japan Diagnostic Nuclear Medicines Market Size (Million USD) (2014-2025)
Figure Southeast Asia Diagnostic Nuclear Medicines Market Size (Million USD) (2014-2025)
Figure India Diagnostic Nuclear Medicines Market Size (Million USD) (2014-2025)
Table Diagnostic Nuclear Medicines Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Diagnostic Nuclear Medicines in 2018
Figure Manufacturing Process Analysis of Diagnostic Nuclear Medicines
Figure Industry Chain Structure of Diagnostic Nuclear Medicines
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Diagnostic Nuclear Medicines Manufacturing Plants Distribution
Table Diagnostic Nuclear Medicines Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Diagnostic Nuclear Medicines Capacity (K Units) of Major Manufacturers (2014-2019)
Table Diagnostic Nuclear Medicines Production (K Units) of Major Manufacturers (2014-2019)
Table Diagnostic Nuclear Medicines Production Market Share of Major Manufacturers (2014-2019)
Figure Diagnostic Nuclear Medicines Production Share by Manufacturers in 2018
Table Diagnostic Nuclear Medicines Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Diagnostic Nuclear Medicines Revenue Market Share of Major Manufacturers (2014-2019)
Figure Diagnostic Nuclear Medicines Revenue Share by Manufacturers in 2018
Table Diagnostic Nuclear Medicines Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Diagnostic Nuclear Medicines Production by Regions 2014-2019 (K Units)
Table Global Diagnostic Nuclear Medicines Production Market Share by Regions 2014-2019
Figure Global Diagnostic Nuclear Medicines Production Market Share by Regions in 2018
Table Global Diagnostic Nuclear Medicines Revenue by Regions 2014-2019 (Million USD)
Table Global Diagnostic Nuclear Medicines Revenue Market Share by Regions 2014-2019
Figure Global Diagnostic Nuclear Medicines Revenue Market Share by Regions in 2018
Table Global Diagnostic Nuclear Medicines Consumption by Regions 2014-2019 (K Units)
Table Global Diagnostic Nuclear Medicines Consumption Market Share by Regions 2014-2019
Figure North America Diagnostic Nuclear Medicines Production Growth Rate 2014-2019 (K Units)
Figure North America Diagnostic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million USD)
Table North America Diagnostic Nuclear Medicines Production, Consumption Import and Export (K Units)
Figure Europe Diagnostic Nuclear Medicines Production Growth Rate 2014-2019 (K Units)
Figure Europe Diagnostic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Diagnostic Nuclear Medicines Production, Consumption Import and Export (K Units)
Figure China Diagnostic Nuclear Medicines Production Growth Rate 2014-2019 (K Units)
Figure China Diagnostic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million USD)
Table China Diagnostic Nuclear Medicines Production, Consumption Import and Export (K Units)
Figure Japan Diagnostic Nuclear Medicines Production Growth Rate 2014-2019 (K Units)
Figure Japan Diagnostic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Diagnostic Nuclear Medicines Production, Consumption Import and Export (K Units)
Figure Southeast Asia Diagnostic Nuclear Medicines Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia Diagnostic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Diagnostic Nuclear Medicines Production, Consumption Import and Export (K Units)
Figure India Diagnostic Nuclear Medicines Production Growth Rate 2014-2019 (K Units)
Figure India Diagnostic Nuclear Medicines Revenue Growth Rate 2014-2019 (Million USD)
Table India Diagnostic Nuclear Medicines Production, Consumption Import and Export (K Units)
Figure Global Consumption Diagnostic Nuclear Medicines Market Share by Application (2014-2019)
Figure Global Value (Consumption) Diagnostic Nuclear Medicines Market Share by Application (2014-2019)
Table Bracco Imaging Diagnostic Nuclear Medicines Production Sites and Area Served
Table Bracco Imaging Diagnostic Nuclear Medicines Product Introduction, Application and Specification
Table Bracco Imaging Diagnostic Nuclear Medicines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bracco Imaging Diagnostic Nuclear Medicines Production Growth Rate (2014-2019)
Table Bracco Imaging Diagnostic Nuclear Medicines Production Market Share (2014-2019)
Figure Bracco Imaging Diagnostic Nuclear Medicines Revenue Market Share (2014-2019)
Table Bracco Imaging Diagnostic Nuclear Medicines Main Business and Markets Served
Table Bayer Diagnostic Nuclear Medicines Production Sites and Area Served
Table Bayer Diagnostic Nuclear Medicines Product Introduction, Application and Specification
Table Bayer Diagnostic Nuclear Medicines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Bayer Diagnostic Nuclear Medicines Production Growth Rate (2014-2019)
Table Bayer Diagnostic Nuclear Medicines Production Market Share (2014-2019)
Figure Bayer Diagnostic Nuclear Medicines Revenue Market Share (2014-2019)
Table Bayer Diagnostic Nuclear Medicines Main Business and Markets Served
Table Curium Pharmaceuticals Diagnostic Nuclear Medicines Production Sites and Area Served
Table Curium Pharmaceuticals Diagnostic Nuclear Medicines Product Introduction, Application and Specification
Table Curium Pharmaceuticals Diagnostic Nuclear Medicines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Curium Pharmaceuticals Diagnostic Nuclear Medicines Production Growth Rate (2014-2019)
Table Curium Pharmaceuticals Diagnostic Nuclear Medicines Production Market Share (2014-2019)
Figure Curium Pharmaceuticals Diagnostic Nuclear Medicines Revenue Market Share (2014-2019)
Table Curium Pharmaceuticals Diagnostic Nuclear Medicines Main Business and Markets Served
Table Nordion Diagnostic Nuclear Medicines Production Sites and Area Served
Table Nordion Diagnostic Nuclear Medicines Product Introduction, Application and Specification
Table Nordion Diagnostic Nuclear Medicines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Nordion Diagnostic Nuclear Medicines Production Growth Rate (2014-2019)
Table Nordion Diagnostic Nuclear Medicines Production Market Share (2014-2019)
Figure Nordion Diagnostic Nuclear Medicines Revenue Market Share (2014-2019)
Table Nordion Diagnostic Nuclear Medicines Main Business and Markets Served
Table Triad Isotopes Diagnostic Nuclear Medicines Production Sites and Area Served
Table Triad Isotopes Diagnostic Nuclear Medicines Product Introduction, Application and Specification
Table Triad Isotopes Diagnostic Nuclear Medicines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Triad Isotopes Diagnostic Nuclear Medicines Production Growth Rate (2014-2019)
Table Triad Isotopes Diagnostic Nuclear Medicines Production Market Share (2014-2019)
Figure Triad Isotopes Diagnostic Nuclear Medicines Revenue Market Share (2014-2019)
Table Triad Isotopes Diagnostic Nuclear Medicines Main Business and Markets Served
Table Lantheus Diagnostic Nuclear Medicines Production Sites and Area Served
Table Lantheus Diagnostic Nuclear Medicines Product Introduction, Application and Specification
Table Lantheus Diagnostic Nuclear Medicines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Lantheus Diagnostic Nuclear Medicines Production Growth Rate (2014-2019)
Table Lantheus Diagnostic Nuclear Medicines Production Market Share (2014-2019)
Figure Lantheus Diagnostic Nuclear Medicines Revenue Market Share (2014-2019)
Table Lantheus Diagnostic Nuclear Medicines Main Business and Markets Served
Table GE Healthcare Diagnostic Nuclear Medicines Production Sites and Area Served
Table GE Healthcare Diagnostic Nuclear Medicines Product Introduction, Application and Specification
Table GE Healthcare Diagnostic Nuclear Medicines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GE Healthcare Diagnostic Nuclear Medicines Production Growth Rate (2014-2019)
Table GE Healthcare Diagnostic Nuclear Medicines Production Market Share (2014-2019)
Figure GE Healthcare Diagnostic Nuclear Medicines Revenue Market Share (2014-2019)
Table GE Healthcare Diagnostic Nuclear Medicines Main Business and Markets Served
Table China Isotope & Radiation Diagnostic Nuclear Medicines Production Sites and Area Served
Table China Isotope & Radiation Diagnostic Nuclear Medicines Product Introduction, Application and Specification
Table China Isotope & Radiation Diagnostic Nuclear Medicines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table China Isotope & Radiation Diagnostic Nuclear Medicines Production Growth Rate (2014-2019)
Table China Isotope & Radiation Diagnostic Nuclear Medicines Production Market Share (2014-2019)
Figure China Isotope & Radiation Diagnostic Nuclear Medicines Revenue Market Share (2014-2019)
Table China Isotope & Radiation Diagnostic Nuclear Medicines Main Business and Markets Served
Table Jubilant Pharma Diagnostic Nuclear Medicines Production Sites and Area Served
Table Jubilant Pharma Diagnostic Nuclear Medicines Product Introduction, Application and Specification
Table Jubilant Pharma Diagnostic Nuclear Medicines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Jubilant Pharma Diagnostic Nuclear Medicines Production Growth Rate (2014-2019)
Table Jubilant Pharma Diagnostic Nuclear Medicines Production Market Share (2014-2019)
Figure Jubilant Pharma Diagnostic Nuclear Medicines Revenue Market Share (2014-2019)
Table Jubilant Pharma Diagnostic Nuclear Medicines Main Business and Markets Served
Table Eli Lilly Diagnostic Nuclear Medicines Production Sites and Area Served
Table Eli Lilly Diagnostic Nuclear Medicines Product Introduction, Application and Specification
Table Eli Lilly Diagnostic Nuclear Medicines Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Diagnostic Nuclear Medicines Production Growth Rate (2014-2019)
Table Eli Lilly Diagnostic Nuclear Medicines Production Market Share (2014-2019)
Figure Eli Lilly Diagnostic Nuclear Medicines Revenue Market Share (2014-2019)
Table Eli Lilly Diagnostic Nuclear Medicines Main Business and Markets Served
Table Novartis Diagnostic Nuclear Medicines Production Sites and Area Served
Table SIEMENS Diagnostic Nuclear Medicines Production Sites and Area Served
Table Dongcheng Diagnostic Nuclear Medicines Production Sites and Area Served
Table Navidea Diagnostic Nuclear Medicines Production Sites and Area Served
Figure Global Diagnostic Nuclear Medicines Production (K Units) Growth Rate Forecast 2019-2025
Figure Global Diagnostic Nuclear Medicines Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Diagnostic Nuclear Medicines Sales Price (USD/Unit) Forecast 2019-2025
Figure North America Diagnostic Nuclear Medicines Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America Diagnostic Nuclear Medicines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Diagnostic Nuclear Medicines Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe Diagnostic Nuclear Medicines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Diagnostic Nuclear Medicines Production Growth Rate Forecast 2019-2025 (K Units)
Figure China Diagnostic Nuclear Medicines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Diagnostic Nuclear Medicines Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan Diagnostic Nuclear Medicines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Diagnostic Nuclear Medicines Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia Diagnostic Nuclear Medicines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Diagnostic Nuclear Medicines Production Growth Rate Forecast 2019-2025 (K Units)
Figure India Diagnostic Nuclear Medicines Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of Diagnostic Nuclear Medicines by Type (2019-2025)
Table Global Consumption (K Units) of Diagnostic Nuclear Medicines by Application (2019-2025)
Table Diagnostic Nuclear Medicines Distributors List
Table Diagnostic Nuclear Medicines Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources